These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35215977)

  • 1. In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack.
    Hussein M; Andrade Dos Ramos Z; Berkhout B; Herrera-Carrillo E
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2.
    Hussein M; Andrade Dos Ramos Z; Vink MA; Kroon P; Yu Z; Enjuanes L; Zuñiga S; Berkhout B; Herrera-Carrillo E
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein.
    Wang L; Zhou J; Wang Q; Wang Y; Kang C
    Theranostics; 2021; 11(2):649-664. PubMed ID: 33391497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics.
    Banerjee A; Mukherjee S; Maji BK
    Exp Biol Med (Maywood); 2021 Jul; 246(14):1643-1649. PubMed ID: 33899542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection.
    Liu Z; Gao X; Kan C; Li L; Zhang Y; Gao Y; Zhang S; Zhou L; Zhao H; Li M; Zhang Z; Sun Y
    MedComm (2020); 2023 Feb; 4(1):e208. PubMed ID: 36744219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance.
    Fareh M; Zhao W; Hu W; Casan JML; Kumar A; Symons J; Zerbato JM; Fong D; Voskoboinik I; Ekert PG; Rudraraju R; Purcell DFJ; Lewin SR; Trapani JA
    Nat Commun; 2021 Jul; 12(1):4270. PubMed ID: 34257311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
    Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
    J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LinearTurboFold: Linear-time global prediction of conserved structures for RNA homologs with applications to SARS-CoV-2.
    Li S; Zhang H; Zhang L; Liu K; Liu B; Mathews DH; Huang L
    Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34887342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology and clinical characteristics of SARS-CoV-2 and other human coronaviruses among children in Zhejiang Province, China 2017-2019.
    Zhang Y; Su L; Chen Y; Yu S; Zhang D; Mao H; Fang L
    Virol J; 2021 Apr; 18(1):89. PubMed ID: 33931105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response.
    Franzo G
    Sci Rep; 2021 May; 11(1):10696. PubMed ID: 34021237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitro.
    Zeng L; Liu Y; Nguyenla XH; Abbott TR; Han M; Zhu Y; Chemparathy A; Lin X; Chen X; Wang H; Rane DA; Spatz JM; Jain S; Rustagi A; Pinsky B; Zepeda AE; Kadina AP; Walker JA; Holden K; Temperton N; Cochran JR; Barron AE; Connolly MD; Blish CA; Lewis DB; Stanley SA; La Russa MF; Qi LS
    Nat Commun; 2022 May; 13(1):2766. PubMed ID: 35589813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Putative long-range RNA-RNA interaction between ORF8 and Spike of SARS-CoV-2.
    Omoru OB; Pereira F; Janga SC; Manzourolajdad A
    PLoS One; 2022; 17(9):e0260331. PubMed ID: 36048827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
    Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.
    Kratzel A; Kelly JN; V'kovski P; Portmann J; Brüggemann Y; Todt D; Ebert N; Shrestha N; Plattet P; Staab-Weijnitz CA; von Brunn A; Steinmann E; Dijkman R; Zimmer G; Pfaender S; Thiel V
    PLoS Biol; 2021 Dec; 19(12):e3001490. PubMed ID: 34962926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
    Robson B
    Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses.
    Lin P; Shen G; Guo K; Qin S; Pu Q; Wang Z; Gao P; Xia Z; Khan N; Jiang J; Xia Q; Wu M
    Nucleic Acids Res; 2022 May; 50(8):e47. PubMed ID: 35166837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.